Introduction
There are three mammalian members of the Cbl (Casitas B-lineage lymphoma) family of proteins: the ubiquitously expressed c-Cbl and Cbl-b, as well as Cbl-3 (also known as Cbl-c) that is expressed primarily in the aerodigestive tract. Collectively, referred to as Cbls, c-Cbl and Cbl-b have similar domains, including a modified EF Hand-containing SH2 domain known as the TKB (tyrosine kinase binding) domain, a regulatory pre-RING linker domain, a RING finger domain, a polyproline domain, and a ubiquitin-associated/leucine zipper domain [1] [2] . c-Cbl and Cbl-b possess E3 ligase activity that requires an intact RING finger domain. They also exhibit the capacity for a number of different protein-protein interactions that appear to have functions independent of the E3 ligase activity.
c-Cbl was first identified through studies on the viral oncogene v-Cbl, a C-terminal truncation of Cbl that is sufficient to induce pre-B-cell lymphomas and myelogenous leukemia in mice [3] . In addition to their ability to transform cells, oncogenic forms of Cbl proteins such as v-Cbl and c-CblΔ371 inhibit apoptosis induced by IL-3 withdrawal in the myeloid cell line 32Dcl13. Oncogenic Cbls also block 32Dcl13 cells from differentiating into granulocytes in response to colony-stimulating factor [4] [5] . The mechanism for apoptosis protection by mutant Cbls seems to involve the elevation of BCL-2 by an unknown means. However, the possible roles of wild-type hibitors YVAD or DEVD [6] . It has also been reported that a c-Cbl-related protein CARP (Cbl-related 90 KD protein), a possible alternatively spliced form of c-Cbl, is upregulated in the thymus of mice treated with hydrocortisone, UV radiation, or anti-CD3 antibody [7] [8] . A knock-in mouse expressing c-Cbl with a point mutation in the RING finger domain that eliminates its E3 ligase activity has complete loss of the thymus by young adulthood. This effect can be explained by increased sensitivity to anti-CD3-induced cell death, at least in vitro [9] . In addition, a T helper 1 cell line derived from Cbl-b null mice had much greater sensitivity to anti-CD3-induced death than a cell line derived from Cbl-b WT mice [10] .
On the other hand, c-Cbl has been shown to mediate FGFR2-mediated apoptosis of osteoblasts by downregulating α5 integrin and reducing cellular attachment [11] .
Finally, c-Cbl knockout mice have reduced levels of apoptosis in the testis [12] . We initially became interested in Cbl proteins after identifying them as binding partners of the c-Jun Nterminal kinase (JNK) pathway scaffold POSH (plenty of SH3 domains). The JNK pathway plays a pivotal role in apoptosis of neurons and other mammalian cell types [13] [14] [15] . In particular, trophic factor deprivation models of neuronal cell death involve a sequential MAP kinase cascade including the mixed lineage kinases (MLKs), MKK 4 and 7 (mitogen-activated protein kinase kinases), and JNKs [14] [15] [16] [17] [18] [19] [20] . Once activated, JNKs then phosphorylate and activate pro-apoptotic targets such as the transcription factor c-Jun [14] [15] . Initiation of the cascade appears to require activated forms of the small GTPases Cdc42 and Rac1 as well as the formation of the multiprotein POSH-JIP apoptotic complex, which includes the scaffold proteins POSH, JIPs (JNK-interacting proteins), and members of the JNK kinase cascade [17] [18] .
An important issue regarding the apoptotic JNKsignaling pathway is how it is suppressed in healthy cells and how it is rapidly activated in response to apoptotic stimuli. Here, we present evidence that Cbl proteins act as a brake on the activation of JNK signaling in healthy neuronal cells and that they are rapidly lost from cells after exposure to apoptotic conditions, thus releasing this brake. Our findings suggest that at least one mechanism for the suppression of JNK signaling by Cbl proteins is by inhibiting the capacity of MLKs to signal to downstream members of the JNK kinase cascade.
Results

Cbl protein levels fall in response to NGF deprivation
A previous report indicated that c-Cbl and Cbl-b are cleaved in Jurkat cells undergoing apoptotic stresses such as DNA damage or exposure to anti-Fas ligand [6] . Here, we assessed the state of Cbl proteins in cultured neuronal cells subjected to trophic factor deprivation, a treatment that triggers early JNK activation and JNK-dependent apoptotic death commencing at about 16-24 h [15, 21] . Neuronal (nerve growth factor (NGF)-pretreated) PC12 cells ( Figure 1A ) and sympathetic ganglionic neurons (SGNs; Figure 1B ) both showed a decrease in full-length c-Cbl expression in response to NGF deprivation. Loss of full-length c-Cbl occurred at times (4-10 h post NGF withdrawal) well before apoptotic cell death and at the time of JNK activation ( Figure 1A ) [21] . Cbl-b protein levels also decreased in response to NGF deprivation in both cell types (Supplementary information, Figure S1 ). This typically occurred at somewhat later time points than for c-Cbl, but before the time at which the majority of cells were committed to die [21] [22] . We did not detect stable fragments produced by c-Cbl cleavage using an antibody directed against the C-terminal portion of this protein (data not shown).
c-Cbl is de-phosphorylated on tyrosine residues in response to NGF deprivation
Cbls are phosphorylated on tyrosine residues downstream of growth factor activation of receptor tyrosine kinases [2, 23] . Of particular relevance, c-Cbl is reported to undergo rapid phosphorylation on tyrosine residues in response to NGF [24] . Such phosphorylation activates the E3 ligase activities of Cbls and promotes their interaction with numerous proteins [1, 2, 23, 25] . We therefore assessed whether NGF deprivation would result in a drop of c-Cbl tyrosine phosphorylation and if this would occur within a time frame that may be relevant to the promotion of death. To address the role of NGF specifically (that is to eliminate any effect of serum), neuronal PC12 cells were initially cultured in RPMI 1640 medium supplemented with NGF and 1% horse serum, followed by 2 days in serum-free RPMI 1640 medium that was supplemented with NGF alone. Cells were then washed in NGF-free medium and treated with either NGF or monoclonal anti-NGF antibody in serum-free RPMI 1640 medium and lysed 3 h later. Immunoblot analysis of immunoprecipitated c-Cbl indicated that the levels of tyrosine-phosphorylated c-Cbl dropped significantly by 3 h of NGF deprivation (45 ± 1.7%; Figure 1C ). Thus, it appears that c-Cbl is both rapidly degraded and rapidly de-phosphorylated in response to the apoptotic stimulus of NGF deprivation.
shRNA-mediated knockdown of Cbl/Cbl-b sensitizes neuronal PC12 cells to NGF deprivation
To mimic the loss of Cbl proteins and their activities caused by NGF deprivation, we designed shRNA plasmids targeting c-Cbl or Cbl-b, utilizing sequences conserved in human, rat, and mouse. We verified the efficacy of these constructs by co-expression of target or control shRNA with HA-tagged human c-Cbl/Cbl-b constructs in HEK 293 cells (Figure 2A ). Knockdown of endogenous rat c-Cbl was confirmed by immunostaining in neuronal PC12 cells ( Figure 2B ). We were unable to identify a commercial Cbl-b antibody that satisfactorily recognized endogenous rat Cbl-b by immunostaining (data not shown). We first determined whether knockdown of Cbls was sufficient to induce death in the presence of trophic support (NGF). Although in one experiment there was a trend toward increased death, this was not a consistent finding (n > 6). In contrast, knockdown of Cbls with shRNA significantly and consistently sensitized neuronal PC12 cells to NGF deprivation ( Figure 2C, D) . While single knockdown of either c-Cbl or Cbl-b had some effect on cell sensitization to death, double knockdown was consistently more effective, as shown in Figure  2C . For this reason, subsequent experiments employed knockdown of both Cbl family members.
Cbls are regulated in camptothecin models of DNA damage and knockdown of Cbls sensitizes neuronal cells to death induced by DNA damage
To determine whether loss of Cbls was limited to NGF deprivation, we treated neuronal PC12 cells and primary embryonic cortical neurons with the DNAdamaging agent camptothecin, a topoisomerase I inhibitor that kills neurons [26] . c-Cbl and Cbl-b protein levels decreased in response to camptothecin exposure in the range of 4-11 h post treatment (Supplementary information, Figure S2A -C), again preceding cell death, which Neuronal PC12 cells were grown in NGF/RPMI 1640 medium/1% horse serum for 4 days followed by 2 days in NGF/RPMI 1640 medium without serum. Cells were washed three times and treated in RPMI 1640 medium with either NGF (+) or monoclonal anti-NGF antibody (-), and lysed 3 h later into IP buffer 2. Aliquots of total lysate were saved for later analysis, while the rest of the NGF (+) and NGF (-) treated lysates were split in half and were subjected to immunopreciptation with either c-Cbl or control IgG antibodies. Resulting immunocomplexes and total lysate controls were subjected to immunoblotting and were probed with anti-phosphotyrosine to detect the total tyrosine phosphorylation status of c-Cbl, and then stripped and re-probed with c-Cbl antibody for loading. Total lysates were also blotted for c-Cbl levels. npg commences at about 18-24 h post treatment [21, 26] . In addition to the loss of full-length Cbl-b, immunoblotting with an N-terminal Cbl-b antibody revealed the appearance of smaller immunoreactive species in lysates of cells subjected to NGF deprivation or camptothecin treatment (Supplementary information, Figure S2B ; data not shown). This suggests that the loss of expression may be due at least in part to protein degradation. Past work has implicated caspases in the degradation of Cbls [6] .
In support of this idea, the pan-caspsase inhibitor t-butoxycarbonyl-aspartyl(OMe)-fluoromethyl ketone (BAF) at least partially blocked the loss of full-length Cbl-b, as well as the formation of presumed cleavage products (Supplementary information, Figure S2B ). We also tested the effect of knocking down both Cbls in camptothecin-treated neuronal PC12 cells. In parallel with our findings for NGF deprivation, cells transfected with shRNAs targeting Cbls were significantly sensitized to camptothecin treatment as compared to those transfected with control shRNAs (Supplementary information, Figure S2D ).
Cbls are regulated by acute exposure to NMDA
To address whether Cbl levels might be regulated in additional paradigms of neuronal death, we examined an acute NMDA model of death in cultured cortical neurons [27] . Both Cbl-b (Supplementary information, Figure  S2E ) and c-Cbl (data not shown) were rapidly decreased in response to NMDA treatment. This effect was significantly blocked by the calpain inhibitor calpeptin, thus indicating a mechanism at least in part dependent on degradation. The formation of presumed cleavage fragments, which were also blocked by calpeptin, still occurred in the presence of Actinomycin D (data not shown), which argues that they are not derived from novel transcripts.
Cbl proteins interact with JNK pathway components
We initially found an association between Cbl proteins and the JNK pathway from a yeast-two hybrid screen that used a full-length construct of the JNK scaffold POSH as bait [28, 29] . This screen identified both c-Cbl and Cbl-b (3/52 hits) as medium/strong binding partners of full-length POSH. We first verified this interaction in HEK293 cells by co-expressing epitope-tagged ∆ZnPOSH (a RING finger domain deletion mutant that is more stable and thus more highly expressed than wt POSH [17] ) and c-Cbl/Cbl-b. Myc-∆ZnPOSH and HAc-Cbl/Cbl-b were co-immunoprecipitated in both directions and this interaction did not require POSH's RING finger domain (Supplementary information, Figure S3 ). To investigate whether the POSH and Cbl protein interaction is direct, we performed GST-pulldowns with N-terminal and C-terminal halves of GST-POSH and in vitro transcribed/translated c-Cbl/Cbl-b (Supplementary information, Figure S3 ). Both halves of POSH pulled down full-length c-Cbl, Cbl-b, and Cbl-b 2/3 (a mutant missing the N-terminal TKB domain). Despite these findings with overexpressed POSH and Cbls, we were unable to demonstrate interaction of the endogenous proteins in multiple co-IP experiments using extracts from both neuronal and non-neuronal cells with or without the use of proteasome inhibitors (data not shown). This suggested either that complexes formed by these proteins were at levels or transitory stabilities below our capacity to detect or that the interaction does not occur under more physiological conditions. Finally, overexpression of either wild-type c-Cbl or the dominant-negative v-Cbl did not appear to affect endogenous POSH levels in 293 cells (Supplementary information, Figure S4 ).
In addition to POSH, MLKs appear to be limiting . Aliquots of total lysate were saved for later analysis, while the rest was split in half and subjected to immunoprecipitation with either IgG (mouse) alone or monoclonal anti-HA antibodies, followed by western blot analysis of MLK3 and HA-c-Cbl. (B) PC12 cells were treated with the proteasome inhibitor Mg132 for 6 h and then were lysed into IP buffer #1. Aliquots of total lysate were saved for later analysis, while the rest was split in half and subjected to immunoprecipitation with either IgG (rabbit) alone or c-Cbl (C-15) antibody, followed by western blot analysis of MLK3 and c-Cbl. Comparable results were found in one experiment with PC12 cell cultures in which no MG132 was added (data not shown).
components of the JNK signaling cascade and inhibition of MLK activity protects neurons from death induced by NGF deprivation or DNA damage [16, 20] . We therefore assessed whether c-Cbl and the MLK family member MLK3 interact. As shown in Figure 3A , overexpressed HA-tagged c-Cbl co-immunoprecipitated with endogenous MLK3 in lysates of 293 cells. In the converse direction, overexpressed tagged MLK3 was able to co-immunoprecipitate tagged c-Cbl (data not shown). In addition, endogenous c-Cbl specifically co-immunoprecipitated with endogenous MLK3 in PC12 cells treated with the proteasome inhibitor MG132 ( Figure 3B ). Similar findings were achieved in cells not exposed to MG132 (data 
Reduction of Cbls via RNAi activates the JNK pathway
Neuronal apoptosis induced by both NGF deprivation and DNA damage is associated with prolonged, moderate (2-3 fold) activation of the JNK-signaling pathway and this activity is required for death [14] [15] [16] 21] . Furthermore, our data indicate that Cbl proteins interact with JNK pathway components and are downregulated/inactivated in response to apoptotic stimuli during time periods that correlate with JNK pathway activation. We therefore assessed the possibility that loss/inactivation of Cbl proteins contributes to the activation of JNK signaling. We utilized HEK 293 cells due to their high transfection efficiencies (in contrast to neuronal PC12 cells and sympathetic neurons, which have transfection efficiencies on the order of 1% or less) to examine the effect of Cbl knockdown on JNK pathway activity. Compared with cells transfected with two control shRNAs, knockdown of both c-Cbl and Cbl-b in HEK 293 cells led to a threefold increase in activation of the JNK-signaling pathway, as indicated by phosphorylation of its target c-Jun at Ser63 ( Figure 4A ). UV irradiation was used as a positive control for JNK pathway activation. We confirmed these results by utilizing commercially available siRNAs targeting human c-Cbl and Cbl-b (Santa Cruz pool of three siRNAs per target), which have targeting sequences different from the shRNA sequences we employed ( Figure  4B ). These findings indicate that loss of Cbls leads to activation of JNK signaling and support the hypothesis that, when present, Cbls provide a brake on JNK signaling.
c-Cbl proteins block MLK signaling in a RING-independent manner
We next investigated the possible mechanisms by which Cbls might suppress JNK signaling in healthy cells. MLKs and POSH, with which Cbls interact, are maintained at low levels in healthy cells and are stabilized in response to apoptotic stimuli, thereby reaching sufficient levels to promote JNK pathway activation and cell death [17, 19] . Because Cbls are E3 ligases, we first investigated whether they might, in healthy cells, promote degradation of POSH whose stability is proteasome-dependent [17] . Overexpressed wild-type c-Cbl or Cbl-b had little to no effect on endogenous POSH expression in HEK293 cells (Supplementary information, Figure S4 and data not shown). Thus it appears that at least under the conditions of our study, Cbls do not target POSH for degradation.
We next assessed whether Cbls might suppress JNK signaling by reducing MLK levels. Unexpectedly, endogenous MLK3 was greatly stabilized by expression of wild-type or RING finger mutant c-Cbl (C381A) as shown in Figure 5A , B. Furthermore, this stabilization also led to elevated levels of phosphorylated (and presumably activated) MLK3 ( next considered the possibility that they might interfere with their ability to promote JNK signaling. As shown in Figures 5A-5C , despite the large increase in level and activation of MLK3 that occurs in the presence of overexpressed c-Cbl, this does not result in enhanced phosphorylation of MKK4, JNKs, or of the JNK substrate c-Jun. As one control for JNK pathway activation, we overexpressed MLK3 at a relatively low level, and even though total cellular levels of this protein did not reach those achieved by overexpression of c-Cbl, there was robust JNK phosphorylation ( Figure 5A ). As another positive control for JNK pathway activation, parallel transfected HEK 293 cells were treated with UV irradiation. In the UV irradiation model of cell death in this cell type, JNK pathway activation appears to be mediated by kinases other than MLKs [30, 31] . UV irradiation led to increased phosphorylation of both MKK4 and c-Jun, and in line with the reported MLK-independent mechanism, this was not affected by c-Cbl overexpression ( Figure 5B, C). These findings thus support the possibility that c-Cbl interferes with the capacity of activated MLKs to signal to downstream components of the JNK cascade, including MKK4, the next component in the cascade.
Overexpression of c-Cbl protects neuronal cells against MLK overexpression in a RING-independent manner
Expression of MLKs promotes JNK-dependent apoptosis in neuronal PC12 cells [16] . If c-Cbl can block the ability of an MLK to activate JNK signaling, it follows that c-Cbl should interfere with the capacity of MLKs to promote cell death. We tested this hypothesis by cotransfecting neuronal PC12 cells with MLK3 or the related family member MLK2 and either empty vector or various c-Cbl constructs, and measuring apoptotic death. We used both wild-type c-Cbl and a reportedly constitutively active E3 ligase version, c-Cbl371E [25] , that has the Y371 activation residue mutated to glutamate to mimic phosphorylation. Expression of either wild type or c-Cbl371E protected the cells against apoptosis induced by MLK overexpression (Figure 6A, B) . We also assessed whether Cbl RING finger activity is required for c-Cbl to block MLK-induced death. As shown in Figure  6A , RING finger mutant c-Cbl-381A also effectively protected cells from MLK3 overexpression. Thus, E3 ligase activity does not appear to be necessary for the capacity of c-Cbl to block MLK death signaling.
Because our findings indicate that c-Cbl blocks JNK signaling at the level of MLKs, we next assessed the capacity of c-Cbl371E to inhibit cell death promoted by a MAPKK downstream of MLKs, MKK7. In this case, there was no suppression of death ( Figure 6C ). Similar results were found in one experiment testing the ability of MKK4 to kill neuronal PC12 cells (data not shown). This is consistent with the model that c-Cbl suppresses the JNK-signaling cascade between MLKs and MKK4/7 and not downstream of MKK4/7 activation. Finally, we tested whether co-expression of Cbl-b protects against overexpression of MLK3 in neuronal PC12 cells and found that in contrast to c-Cbl, it does not ( Figure 6D ). To determine whether the capacity of c-Cbl to protect cells from MLK3-promoted death correlates with its ability to inhibit JNK signaling, we co-transfected HEK293 cells with MLK3 in the presence or absence of c-Cbl or Cbl-b and assessed JNK phosphorylation. As shown in Figure 6E , c-Cbl significantly diminished JNK activation, while there was no significant effect of Cbl-b.
Discussion
Given that a previous report indicated that Cbl protein levels fall during apoptotic stress in Jurkat cells [6] and our interest in potential effectors of neuronal cell death, we examined whether Cbl levels also fall in neuronal death models. The levels of c-Cbl and Cbl-b proteins were both reduced in response to NGF deprivation and camptothecin treatment. In addition to being cleaved in response to NGF deprivation, c-Cbl also underwent rapid loss of tyrosine phosphorylation. Mutational studies suggest that phosphorylation at tyrosine 371 of c-Cbl promotes its E3 ligase activity, whereas deletion of this residue is oncogenic [25, 32] . In addition, phosphorylation at three C-terminal tyrosine residues promotes the interaction of c-Cbl with a variety of proteins, such as Vav, Crk proteins, and the p85 subunit of PI3K [1] . One would therefore predict that decreased tyrosine phosphorylation should diminish c-Cbl's E3 ligase activity as well as its binding to many partners. Taken together, our findings indicate that apoptotic stimuli lead to a rapid loss of c-Cbl and Cbl-b protein levels in neuronal cells and a potential loss of c-Cbl activity, and that these effects occur well before the onset of cell death.
To examine the significance of reduced Cbl proteins and their activities, we mimicked this effect utilizing shRNAs targeting Cbls. Knockdown of Cbls, while not sufficient to promote significant death of neuronal PC12 cells on its own, sensitized them to NGF withdrawal and camptothecin treatment. In a number of cases, such as for EGF, PDGF, and SCF receptors among others, Cbls act as E3 ligases to promote receptor degradation [1, 2, 23, 33] . In these instances, loss of Cbls or of Cbl activity would be expected to strengthen survival signaling by increasing the number of receptors at the cell surface. However, TrkA, the receptor for NGF, phosphorylates (and presumably activates) c-Cbl without being downregulated in turn ( [34] ; Sproul A, Greene L, unpublished observations). Thus, neurons that do not compete well for limited supplies of NGF during development would undergo loss of Cbl protein and activity without a compensatory increase in Trk signaling and thus undergo a more efficient death process.
It is likely that this sensitization to cell death reflects effects of Cbl knockdown on multiple signaling pathways, as c-Cbl has been found to interact with over 150 proteins [1] . We focused here on the JNK pathway, a critical mediator of neuron death activated by NGF withdrawal and other apoptotic stimuli [13] [14] [15] . We observed that Cbl can interact with two JNK pathway components, MLK3 and POSH. Moreover, loss of Cbl proteins correlates temporally with the two-to three-fold activation of the JNK pathway that occurs in response to NGF deprivation. In support of a role for Cbls in regulation of JNK signaling, knockdown of Cbls in HEK 293 cells (a system in which transfection efficiencies are high enough to carry out biochemical studies) was sufficient to promote JNK activation by two-to three-fold. Recent findings indicate that physiological activation of JNK signaling is necessary, but not sufficient to trigger neuronal death [35] . Such observations may explain why loss of Cbls, although sufficient to activate JNK signaling, sensitizes neuronal cells to death but does not trigger apoptosis on its own.
An additional goal of our study was to determine how Cbls might suppress JNK signaling in healthy cells and how loss/inactivation of Cbl proteins in response to apoptotic stimuli could trigger activation of JNK signaling. An obvious mechanism by which Cbls might block JNK signaling would be via E3 ligase-dependent turnover of POSH or MLKs whose levels are low in healthy neuronal cells and rise in response to apoptotic stimuli [16, 17, 19, 20] . However, this was not the case and unexpectedly c-Cbl, but not Cbl-b, stabilized endogenous and overexpressed MLK3 and elevated its phosphorylation levels at autophosphorylation sites that are critical for MLK3 activity [36] . Nevertheless, while overexpressed c-Cbl stabilized "activated" MLK3, it suppressed its capacity to promote phosphorylation and activation of c-Jun, JNK, and MKK4/7, as well as to induce neuronal cell death. Thus, c-Cbl appears to suppress JNK signaling after MLK activation, and this brake is released in response to apoptotic stress (Figure 7 , model). It is probable that there are additional mechanisms by which Cbls inhibit JNK activation, particularly for Cbl-b, which in contrast to c-Cbl, does not stabilize MLK3 or block MLK3-induced apoptosis or JNK activation. For example, Cbl-b (as well as c-Cbl) has been reported to inhibit the ability of the GEF Vav to activate JNKs [37, 38] .
The mechanism by which c-Cbl suppresses signaling between MLKs and MKKs is presently unclear. Our findings indicate that c-Cbl's E3 ligase activity is not required for this effect and therefore that it likely involves a non-catalytic protein-protein interaction. Preliminary evidence suggests that c-Cbl does not interfere with the [39] [40] [41] . For instance, a mutation in MLK3 that prevents oligomerization, but still allows its activation by Cdc42 prevents it from activating JNKs. Our findings that MLK3 and c-Cbl can be isolated within the same complex raises the possibility that such an interaction leads to inhibition of MLK signaling, perhaps by interfering with their oligomerization. In summary, our findings support a model in which Cbls suppress apoptotic JNK signaling in healthy neurons. This occurs at least in part by interference with the capacity of activated MLKs to signal to downstream components in the JNK-signaling cascade. In response to apoptotic stimuli such as NGF deprivation and DNA damage, Cbls levels rapidly fall, relieving their inhibition of apoptotic JNK signaling.
Cbls and MLKs are widely distributed. Although we have focused on a neuronal context, it is likely that the mechanism proposed here also pertains to MLKdependent death in other cell types. Moreover, inhibition of MLK/JNK signaling by Cbls may be important in additional contexts in which these kinases regulate cellular behavior.
Materials and Methods
Antibodies
Anti c-Cbl (C-15), Cbl-b (G1), ERK, Myc, and control IgGs from rabbit and mouse were purchased from Santa Cruz (Santa Cruz, CA, USA). Anti-phospho MLK3 (Thr 277/Ser281), MLK3, phospho JNK (Thr183/Tyr185), JNK, phospho MKK4 (Ser257/ Thr261), MKK4, phospho MKK7 (Ser271/Thr275), MKK7, phospho c-Jun (Ser63 and Ser73), and c-Jun antibodies were from Cell Signaling (Beverly, MA, USA). Anti-NGF, FLAG, HA (rabbit), PY20 (phospho-tyrosine) antibodies were from Sigma (St Louis, MO, USA). Anti-POSH antibody was from Abnova (Taiwan). Anti-HA (mouse) was from Covance (Berkeley, CA, USA).
Chemicals and reagents
Anti-human recombinant NGF, camptothecin, anti-c-Myc agarose conjugate, and Hoechst dye 33342 were from Sigma. Protein A Sepharose 4 Fast Flow beads and ECL were from GE Healthcare (Piscataway, NJ, USA). Super Signal West Dura Extended Duration Substrate and mouse and rabbit secondary HRP-conjugated antibodies were from Pierce (Rockford, IL, USA). NuPAGE BisTris Protein Gels, Lipofectamine 2000, and secondary antibodies for immunofluorescence studies (Molecular Probes), were from Invitrogen (Carlsbad, CA, USA). Anti-mouse IgG conjugated to IRDye 800 was purchased from Rockland (Gilbertsville, PA, USA). BAF was purchased from Enzyme Systems Products (Livermore, CA, USA) and calpeptin from Calbiochem (EMD, Gibbstown, NJ, USA).
Cell culture, transfections, and assessment of cell death
Naïve PC12 cells were grown on collagen-coated plates in RPMI 1640 medium supplemented with 10% horse serum and 5% fetal bovine serum. Neuronally differentiated PC12 and dissociated rat superior cervical SGNs were grown in RPMI 1640 medium supplemented with recombinant human NGF (50 ng/ml, kindly provided by Genetech Inc.) and 1% horse serum as described previously [16] . Cortical rat neurons used for camptothecin studies were dissected at age E19, plated on polylysine, and grown in DMEM/F12 medium supplemented as described previously [19] . E19 Embryonic cortical neurons utilized for NMDA experiments were grown in Neurobasal medium with the addition of B27 Supplement without antioxidants (Invitrogen) for 13 days postplating before acute 20 minutes treatment with 300 μM NMDA or mock treatment in Earl's basal salts as has been done previously, with the change of re-adding conditioned media post treatment [27] . PC12 and primary neurons were transfected with Lipofectamine 2000 as per the manufacturer's instructions (Invitrogen). HEK 293 cells were cultured in plastic culture dishes and grown in DMEM supplemented with 10% fetal bovine serum, and transfected as transcribed previously [16] , with Expressfect as per the manufacturer's instruction (Denville Scientific, Metuchen, NJ, USA), or with RNAimax as per the manufacturer's instructions (Invitrogen). All survival (by strip counting) or death assays (apoptotic nuclear morphology) were scored blindly as described previously [16] .
Plasmids and RNAi
Myc-POSH, Myc-ΔZnPOSH, GST-POSH N and C-terminus, Flag-MLK3, HA-MLK2, MKK4, and MKK7 constructs have been described previously [16, 17] .
pCefl.HA-c-Cbl, pCefl.HA-c-Cbl C381A, pCefl.HA-Cbl-b, pCefl.Cbl-b C373A, pCefl.Cbl-b C 2/3, and empty pCefl vector were generously given by Dr Stanley Lipkowitz (National Cancer Institute, MD, USA). pCMS.EGFP was cut with EcoR1 and blunted with Klenow to sub-clone Cbl constructs. pCMS.EGFP.c-Cbl and c-Cbl C381A were generated by excision of c-Cbl from the pCefl vector utilizing BamH1, blunting with Klenow , and ligating into blunted pCMS.EGFP. pCMS.EGFP.Cbl-b, Cbl-b C373A, and Cbl-b 2/3 were generated by excision of Cbl-b from the pCefl vector utilizing HindIII and Kpn1, blunting with Klenow, and ligating into blunted pCMS.EGFP. pCMS.EGFP.Flag-v-Cbl was constructed by PCR amplification of pCMS.EGFP.HA-c-Cbl utilizing the following primers, cutting the amplicon with Xho1/Xba1 and cloning into similarly cut pC efl vector.
5′ CTC GAG AAC CAT GGA CTA CAA GGA CGATGA TGA CAA AGC CGG CAA CGT GAA GAA GAG C.
3′ TGT GTC TAG ATC AGG GAG TTG GTT CAC ATA AGC CAG.
pCefl.c-Cbl 371E (constitutive active) was constructed utilizing the QuikChange sited directed mutagenesis kit (Stratagene), using the following primers:
5′ GTG ACC CAG GAA CAA TAT GAA TTA GAG TGT GAG ATG GGC TCC ACA TTC C 3′ GGA ATG TGG AGC CCA TCT CAC ACT CTA ATT CAT ATT GTT CCT GGG TCA C shRNA targeting c-Cbl and Cbl-b were constructed by using pSiren vector kits (pSiren and pSiren-DsRed Xpress for both constructs) as per the manufacturer's instructions, utilizing their shLuciferase (shControl) primers as well as the following (target sense sequence underlined):
c-Cbl Sense_GAT CCG ACG GTG GAC AAG AAG ATG GTG GTT CAA GAG ACC ACC ATC TTC TTG TCC ACC GTT TTT TTG G Antisense_AAT TCC AAA AAA ACG GTG GAC AAG AAG ATG GTG GTC TCT TGA ACC ACC ATC TTC TTG TCC Cbl-b Sense_GAT CCG ATC TTC AGT CAC ATG CTG GCA GTT CAA GAG ACT GCC AGC ATG TGA CTG AAG ATT TTT TTG G Antisense_AAT TCC AAA AAA ATC TTC AGT CAC ATG CTG GCA GTC TCT TGA ACT GCC AGC ATG TGA CTG AAG ATG G shLuciferase EGFP (shControl EGFP) and shCbl-b EGFP were constructed by excising the shRNA sequence and upstream U6 promoter out of the pSiren vector via bgI1 and EcoR1, followed by ligation into similarly cut pCMS.EGFP (which lost the CMV promoter region but retained the EGFP cistron).
siRNA oligos were purchased from Invitrogen, and include siCbl h2 (sc-44254), siCbl-b h, (sc-29950), control siRNA-A (sc-37007), and control siRNA-B (sc-44230).
Co-Immunoprecipitation, immunoblotting and in vitro binding assays
Co-immunoprecipitation and immunoblotting and in vitro binding assays were performed as previously described except as noted below [16, 17] . pCefl.c-Cbl, pCefl.Cbl-b, and pCefl.Cbl-b 2/3 was used for in vitro transcription and translation using the TNT-coupled reticulocyte lysate system (Promega, Madison, WI, USA). IP buffer #1 was as described previously [17] . IP Buffer #2 was used for immunoprecipitation of c-Cbl for phospho-tyrosine analysis, and is composed of the following made in 1 x TBS final: 1% Triton X, 0.5% Deoxycholate, 0.1% SDS, 1mM EDTA, 1mM Vanadate, and protease inhibitor tablet (Roche).
